Endpoints News – Biotech, drug, pharma and health news for …
WEBThe FDA's Office of Prescription Drug Promotion sent a letter to AbbVie late last month, calling out the company for what it said was a misleading migraine drug tele ...
Months after massive Ipsen deal, BAKX Therapeutics nets more …
WEBNov 18, 2021 · Months after massive Ipsen deal, BAKX Therapeutics nets more cash for its 'Thelma and Louise' approach to cancer cell death
Endpoints Careers - Find your next biopharma job
WEBAll companies with an Enterprise subscription to Endpoints News will now receive two spotlight job postings per year at no charge. Contact your company subscriptions manager or DeAna ([email protected]) for more information. For sales inquires or package requests, connect with Meg at [email protected].
Back to the fundamentals: Frazier rolls out $1B fund to ramp up a …
WEBMar 16, 2022 · Less than a year after Frazier Healthcare Partners debuted an $830 million public fund for life science investments, the VC is back with even more …
The Biotech landscape: Market trends, priorities, predictions, and ...
WEBAs we adjust to the post-COVID environment, hear from industry leaders about the biotech global investment and drug pipeline environment. In addition, we'll look at why biotech companies are increasingly exploring clinical opportunities in APAC, to achieve FDA accepted data and what actionable strategies can be implemented to leverage APAC’s streamlined regulatory processes and accelerated ...
Endpoints News – The biopharma world is here
WEBEndpoints News – The biopharma world is here. Get the latest reports on drug development, clinical trials, deals and more from the industry experts.
It’s mission critical this time as biotech looks to bounce back
WEBNow it’s time to fix that. Getting together, exploring new deals, hoping someone uncorks a whopper of a buyout, all while assessing the year ahead — these are all annual traditions set to make a comeback at the start of 2023. And this year Endpoints News will be at the heart of it all, offering a hybrid slate of events that will be both ...
Endpoints at #JPM22 - A look at what's to come in 2022
WEBEndpoints has been there to chronicle it with wall-to-wall coverage, and our founder and editor John Carroll has convened top newsmakers to provide detailed insights about their strategies. For #JPM22, Endpoints is expanding on our proud tradition with multiple panels addressing the most important issues in biopharma R&D. title sponsor.
Alphabet’s AI unit Isomorphic inks drug discovery deals with Eli …
WEBJan 7, 2024 · Isomorphic Labs, Alphabet’s closely watched AI startup, has signed its first pharma partnerships, and will work with Eli Lilly and Novartis in deals that could be worth ...
FDA Commissioner Robert Califf highlights need for ‘creative …
WEBJan 30, 2024 · The FDA’s top officials continue to call for new ways to regulate up-and-coming medicines for rare and ultra-rare diseases.
Skip to content